Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学RET Fusions, Asian NSCLC

Byung-Chul Cho

MD, PhD

🏢Yonsei Cancer Center🌐South Korea

Professor of Oncology

55
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Byung-Chul Cho is a prominent thoracic oncologist at Yonsei Cancer Center who has contributed significantly to understanding RET fusion-positive lung cancer in Asian populations. He has led multiple pivotal trials examining selpercatinib and pralsetinib for RET-altered cancers. His work highlights differential fusion frequencies and treatment outcomes in East Asian versus Western patients.

Share:

🧪Research Fields 研究领域

RET fusions NSCLC
selpercatinib
pralsetinib
Korean oncology
lung cancer targeted therapy

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Byung-Chul Cho 的研究动态

Follow Byung-Chul Cho's research updates

留下邮箱,当我们发布与 Byung-Chul Cho(Yonsei Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment